(Bloomberg) — CVS Health Corp. plans to buy back as much as $10 billion of stock and pay out more cash to shareholders as the biggest U.S. seller of prescription drugs benefits from the increasing number of Americans with insurance coverage.
The share buyback will occur over a multi-year period, the Woonsocket, Rhode Island-based company said in a statement today before a briefing for analysts and investors. CVS will raise its quarterly dividend by 27 percent, to 35 cents a share, the company said.
"We've established a solid track record of delivering on our promises, and our results prove that out," Chief Financial Officer Dave Denton said in the statement. "Looking ahead, we are targeting solid, long-term enterprise growth and expect to generate a significant amount of cash that will be available to enhance returns."
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
